News

Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, announces that the European Medicines Agency…
Read More...

Appili Therapeutics Inc. a biopharmaceutical company focused on anti-infective drug development, announced  that investigators have dosed the first participant in its Phase 3 trial…
Read More...

Merck KGaA, Darmstadt, Germany, a leading science and technology company and Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of…
Read More...

Roche announced that its Elecsys Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The serology (blood)…
Read More...

Exelixis, Inc., Iconic Therapeutics, Inc. (Iconic) and Zymeworks Inc. announced that Exelixis has exercised its exclusive option for Iconic’s lead oncology antibody-drug conjugate (ADC)…
Read More...

The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. The purchase agreement is for…
Read More...

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced the acquisition of rights to Hemera Biosciences, LLC's investigational…
Read More...

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of…
Read More...

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics,  announced that its partner, BeiGene, Ltd., has dosed the first patient in South…
Read More...

Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after…
Read More...

atbtherapeutics, a pioneering biopharmaceutical company building an oncology pipeline using its antibody–toxin-bioengineered “atbody”, announces that it has entered a long-term…
Read More...

Tubulis, WuXi STA and WuXi Biologics announced a strategic collaboration to manufacture and advance Tubulis' next generation antibody-drug conjugates (ADCs) towards IND-enabling…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on…
Read More...

CHO Plus, an early-stage innovation company developing technology to vastly increase the productivity of cells used to manufacture therapeutic proteins, announced that it has entered…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply…
Read More...

Telix Pharmaceuticals Limited announces it has entered into an agreement with Scintec Diagnostics GmbH (‘Scintec’) to acquire TheraPharm GmbH (‘TheraPharm’), a Swiss-German…
Read More...

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research collaboration agreement with Cedilla Therapeutics, Inc. a private biotechnology company…
Read More...

FibroGen, Inc. and Astellas Pharma Inc.  announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO (roxadustat) for the treatment of anemia of chronic kidney…
Read More...

Haoma Medica announced the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for…
Read More...

Merck announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung…
Read More...